免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT:NCT04876963 · COMPLETED

NCT IDNCT04876963
狀態COMPLETED
開始日期2021-09-01
完成時間2025-12-31
SponsorRigshospitalet, Denmark (OTHER)
First posted
Last updated

簡要摘要

The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observation period in order to identify arrhythmia burden and type and characterize associations with patient characteristics and dialysis treatment, glycemic variability and subsequent risk of adverse outcomes.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑